Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Athersys Inc (NQ: ATHX )

1.275 USD +0.025 (+2.00%)
Streaming Delayed Price Updated: 2:29 PM EDT, Oct 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Athersys Inc

Notable Monday Option Activity: ATHX, ZG, SHAK
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Athersys Inc (ATHX), where a total of 5,846 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
First Week of ATHX December 17th Options Trading
Investors in Athersys Inc (ATHX) saw new options begin trading this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AXLA PCRX BIVI
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ... 
Tags APTO VACC IONS
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ELDN NVO News
From Benzinga
Interesting ATHX Call Options For January 2024
Investors in Athersys Inc (ATHX) saw new options begin trading this week, for the January 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
Notable Tuesday Option Activity: ELS, ATHX, REKR
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Equity Lifestyle Properties Inc (ELS), where a total of 1,945 contracts have traded so far,... 
Tags Stocks
From Market News Video
Notable Tuesday Option Activity: CLF, ATHX, BRSP
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cleveland-Cliffs Inc (CLF), where a total volume of 242,343 contracts has been... 
Tags Stocks
From Market News Video
Athersys (ATHX) Q2 2021 Earnings Call Transcript
ATHX earnings call for the period ending June 30, 2021. 
Tags ATHX Market News
From Motley Fool
Athersys: Q2 Earnings Insights
Shares of Athersys (NASDAQ:ATHX) increasedin after-market trading after the company reported Q2 results. Quarterly ... 
Tags Earnings BZI/Recaps Benzinga
From Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ... 
Tags SYBX KMPH HOOK
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Nuwellis (NASDAQ:NUWE) shares increased by 5.63% to $4.5 during Friday's after-market session. The market value of their ... 
Tags ATIP Benzinga PRTK
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Applied Molecular (NASDAQ:AMTI) shares increased by 19.38% to $35.54 during Friday's pre-market session. The ... 
Tags Top Gainers Pre/Market Outlook SRTS
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NVO BIO KIDS
From Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ATHX DRRX ZGNX
From Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TCDA PYPD BTAI
From Benzinga
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 29 stocks hit new 52-week lows. Points of Interest: The largest company by ... 
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Evaxion Biotech (NASDAQ:EVAX) shares moved upwards by 16.07% to $6.5 during Friday's after-market session. Trading volume for ... 
From Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
Stocks That Hit 52-Week Lows On Monday
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a ... 
From Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
Athersys (ATHX) Q1 2021 Earnings Call Transcript
ATHX earnings call for the period ending March 31, 2021. 
From Motley Fool
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA ... 
From Benzinga
First Week of ATHX June 18th Options Trading
Investors in Athersys Inc (ATHX) saw new options become available this week, for the June 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options chain... 
From Market News Video
Why Athersys Stock Jumped Today
The biotech's partner completed enrollment in a key clinical study. 
From Motley Fool
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
Athersys (ATHX) Q4 2020 Earnings Call Transcript
ATHX earnings call for the period ending December 31, 2020. 
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.